These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5664149)

  • 1. The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
    Rand MJ; Trinker FR
    Br J Pharmacol Chemother; 1968 Jun; 33(2):287-303. PubMed ID: 5664149
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.
    Trinker FR; Fearn H; McCulloch MW; Rand MJ
    Aust Dent J; 1967 Aug; 12(4):297-303. PubMed ID: 5233628
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of nialamide, pargyline and tranylcypromine on the removal of amphetamine by the perfused liver.
    Trinker FR; Rand MJ
    J Pharm Pharmacol; 1970 Jul; 22(7):496-9. PubMed ID: 4395053
    [No Abstract]   [Full Text] [Related]  

  • 4. TACHYPHYLAXIS TO SOME SYMPATHOMIMETIC AMINES IN RELATION TO MONOAMINE OXIDASE.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1963 Aug; 21(1):84-96. PubMed ID: 14066154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine tachyphylaxis and effects on indirectly-acting sympathomimetic drugs in the rabbit aortic strip and in splenic tissue.
    Maengwyn-Davies GD; Koppanyi T
    J Pharmacol Exp Ther; 1966 Dec; 154(3):481-92. PubMed ID: 5928248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.
    Clarke DE; Leach GD
    Br J Pharmacol Chemother; 1968 Feb; 32(2):392-401. PubMed ID: 4384657
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation.
    Smith CB
    J Pharmacol Exp Ther; 1966 Feb; 151(2):207-20. PubMed ID: 5932599
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of vascular actions of sympathomimetic drugs by methyldopa.
    Sogani RK; Sharma VN
    Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):135-9. PubMed ID: 5918752
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES IN CARDIAC NECROSIS. I. PRODUCTION OF CARDIAC LESIONS WITH SYMPATHOMIMETIC AMINES.
    ROSENBLUM I; WOHL A; STEIN AA
    Toxicol Appl Pharmacol; 1965 Jan; 7():1-8. PubMed ID: 14256598
    [No Abstract]   [Full Text] [Related]  

  • 20. A method for the isolation and determination of 3-methoxytyramine in brain tissue.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):149-58. PubMed ID: 4277335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.